• Contact
  • Login
  • Contact
  • Login
  • TTM2

  • Menu
  • Contact
  • Login
  • About the study
    • History
    • Who are we
  • News
  • Documents
  • Sites
  • Partners
  • Substudies

Vanguard sites and protocol update 1.1

05 December 2017

In an initial phase of the TTM2-trial we have started randomisation at a few vanguard sites, to identifity any potential practical issues with randomisation and the study protocol. Three Swedish sites have now randomised 5 partipants in total and hopefully more will join soon! We will shortly publish a summary of initial experiences from the first sites, which will hopefully help avoid some pitfalls for hospitals joining during 2018. 

To coincide with the commencement of randomisation we have also published an updated version of the protocol (available in documents section). All changes are described in the appendix. 

News

Past 500

15 January 2019

Newsletter Dec - 12

12 December 2018

Screening Log

12 December 2018

Inclusion update (Nov 19) - 332 participants

19 November 2018

Neurofilament article in JAMA Neurology

30 October 2018

Inclusion update (Oct 25) - 267 participants,

25 October 2018

Neuroprognostication videos

17 September 2018

Site inclusion update

04 September 2018

August Update - 192 participants

29 August 2018

eCRF going live and some temporary procedures.

04 May 2018

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

Helsingborg Hospital 
Anaesthesiology and Intensive Care 
Charlotte Yhlens gata 10
251 87 Helsingborg, Sweden
ttm2@ttm2trial.org

Skåne University Hospital
Center for Cardiac Arrest
Barngatan 2A, Practicum
22185 Lund, Sweden
ttm2@ttm2trial.org